Mon, Dec 15, 2025
[Archive]
Volume 17, Issue 3 (September-2025 2025)
Iranian Journal of Blood and Cancer 2025, 17(3): 14-25 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kumar A, Singh Matreja P, Kumar Singh V, Awasthi S. Comparison of Cytochemistry and Flow Cytometry for Leukemia Immunophenotyping: A Systematic Review and Meta-Analysis. Iranian Journal of Blood and Cancer 2025; 17 (3) :14-25
URL: http://ijbc.ir/article-1-1776-en.html
URL: http://ijbc.ir/article-1-1776-en.html
1- Department of General Medicine, Teerthanker Mahaveer Medical College & Research Centre,Teerthanker Mahaveer University, Moradabad, UP, India. , drajaykumar30july@gmail.com
2- Department of Pharmacy, Teerthanker Mahaveer Medical College & Research Centre, Teerthanker Mahaveer University, Moradabad, UP, India.
3- Department of General Medicine, Teerthanker Mahaveer Medical College & Research Centre,Teerthanker Mahaveer University, Moradabad, UP, India.
4- Department of Pathology, Teerthanker Mahaveer Medical College & Research Centre,Teerthanker Mahaveer University, Moradabad, UP, India.
2- Department of Pharmacy, Teerthanker Mahaveer Medical College & Research Centre, Teerthanker Mahaveer University, Moradabad, UP, India.
3- Department of General Medicine, Teerthanker Mahaveer Medical College & Research Centre,Teerthanker Mahaveer University, Moradabad, UP, India.
4- Department of Pathology, Teerthanker Mahaveer Medical College & Research Centre,Teerthanker Mahaveer University, Moradabad, UP, India.
Abstract: (426 Views)
Background: Accurate diagnosis and classification of leukemia are essential for effective treatment planning. Traditional cytochemistry relies on enzyme-based staining for morphological evaluation, while flow cytometry (FCM) employs monoclonal antibodies to detect multiple surface and intracellular markers. This systematic review and meta-analysis compared the diagnostic accuracy of cytochemistry and FCM in leukemia immunophenotyping.
Methods: A systematic search of PubMed and Google Scholar was conducted according to PRISMA guidelines. Studies evaluating sensitivity, specificity, and accuracy of cytochemistry and FCM in diagnosing acute and chronic leukemia were included. Data extraction covered study characteristics, diagnostic markers, and performance outcomes. Meta-analysis was performed to compare diagnostic values across methods.
Results: Eleven eligible studies comprising pediatric and adult leukemia cases were analyzed. Cytochemical stains such as Myeloperoxidase (MPO) and Sudan Black B (SBB) showed high specificity (91–100%) and moderate-to-high sensitivity (60–97%), while Periodic Acid–Schiff (PAS) and Nonspecific Esterase (NSE) had lower reliability. FCM demonstrated superior diagnostic performance with average sensitivity of 87.7% and specificity of 85.6%, achieving >95% accuracy in several studies. Marker panels including CD3, CD45, CD79a, and MPO enabled precise subtype differentiation and minimal residual disease (MRD) detection.
Conclusion: Cytochemistry remains useful as an affordable screening tool in resource-limited settings, but FCM provides greater sensitivity, specificity, and comprehensive immunophenotypic data, making it the preferred method for leukemia diagnosis and monitoring. Combining both approaches can enhance diagnostic performance across diverse clinical contexts.
Methods: A systematic search of PubMed and Google Scholar was conducted according to PRISMA guidelines. Studies evaluating sensitivity, specificity, and accuracy of cytochemistry and FCM in diagnosing acute and chronic leukemia were included. Data extraction covered study characteristics, diagnostic markers, and performance outcomes. Meta-analysis was performed to compare diagnostic values across methods.
Results: Eleven eligible studies comprising pediatric and adult leukemia cases were analyzed. Cytochemical stains such as Myeloperoxidase (MPO) and Sudan Black B (SBB) showed high specificity (91–100%) and moderate-to-high sensitivity (60–97%), while Periodic Acid–Schiff (PAS) and Nonspecific Esterase (NSE) had lower reliability. FCM demonstrated superior diagnostic performance with average sensitivity of 87.7% and specificity of 85.6%, achieving >95% accuracy in several studies. Marker panels including CD3, CD45, CD79a, and MPO enabled precise subtype differentiation and minimal residual disease (MRD) detection.
Conclusion: Cytochemistry remains useful as an affordable screening tool in resource-limited settings, but FCM provides greater sensitivity, specificity, and comprehensive immunophenotypic data, making it the preferred method for leukemia diagnosis and monitoring. Combining both approaches can enhance diagnostic performance across diverse clinical contexts.
: Review Article |
Subject:
Pathology
Received: 2025/08/19 | Accepted: 2025/09/11 | Published: 2025/09/30
Received: 2025/08/19 | Accepted: 2025/09/11 | Published: 2025/09/30
References
1. Epstein, F. H.; Cline, M. J. The Molecular Basis of Leukemia. N Engl J Med 1994, 330 (5), 328-336.
https://doi.org/10.1056/NEJM199402033300507 [DOI:10.1056/NEJM199402033300507.]
2. Kampen, K. R. The Discovery and Early Understanding of Leukemia. Leukemia Research 2012, 36 (1), 6-13.
https://doi.org/10.1016/j.leukres.2011.09.028 [DOI:10.1016/j.leukres.2011.09.028.]
3. Tebbi, C. K. Etiology of Acute Leukemia: A Review. Cancers 2021, 13 (9), 2256.
https://doi.org/10.3390/cancers13092256 [DOI:10.3390/cancers13092256.]
4. Gralnick, H. R.; Galton, D. A. G.; Catovsky, D.; Sultan, C.; Bennett, J. M. Classification of Acute Leukemia. Ann Intern Med 1977, 87 (6), 740-753.
https://doi.org/10.7326/0003-4819-87-6-740 [DOI:10.7326/0003-4819-87-6-740.]
5. Schumacher, H. R.; Alvares, C. J.; Blough, R. I.; Mazzella, F. Acute Leukemia. Clinics in Laboratory Medicine 2002, 22 (1), 153-192.
https://doi.org/10.1016/S0272-2712(03)00071-4 [DOI:10.1016/S0272-2712(03)00071-4.]
6. Lin, K.; Austin, G. Functional Activity of Three Distinct Myeloperoxidase (MPO) Promoters in Human Myeloid Cells. Leukemia 2002, 16 (6), 1143-1153.
https://doi.org/10.1038/sj.leu.2402514 [DOI:10.1038/sj.leu.2402514.]
7. Verigou, E.; Chatzilygeroudi, T.; Lazaris, V.; De Lastic, A.-L.; Symeonidis, A. Immunophenotyping Myelodysplastic Neoplasms: The Role of Flow Cytometry in the Molecular Classification Era. Front. Oncol. 2024, 14, 1447001.
https://doi.org/10.3389/fonc.2024.1447001 [DOI:10.3389/fonc.2024.1447001.]
8. on behalf of the EuroFlow Consortium; Van Dongen, J. J. M.; Orfao, A. EuroFlow: Resetting Leukemia and Lymphoma Immunophenotyping. Basis for Companion Diagnostics and Personalized Medicine. Leukemia 2012, 26 (9), 1899-1907.
https://doi.org/10.1038/leu.2012.121 [DOI:10.1038/leu.2012.121.]
9. Bain, B. J.; Béné, M. C. Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia. Acta Haematol 2019, 141 (4), 232-244.
https://doi.org/10.1159/000496097 [DOI:10.1159/000496097.]
10. Koeffler, H.; Ranyard, J.; Pertcheck, M. Myeloperoxidase: Its Structure and Expression during Myeloid Differentiation. Blood 1985, 65 (2), 484-491.
https://doi.org/10.1182/blood.V65.2.484.484 [DOI:10.1182/blood.V65.2.484.484.]
11. Charak, B. S.; Advani, S. H.; Karandikar, S. M.; Parikh, P. M.; Nair, C. N.; Das Gupta, A.; Gopal, R.; Tapan, K. S.; Nadkarni, K. S.; Kurkure, P. A.; Pai, S. K.; Pai, V. R. Sudan Black B Positivity in Acute Lymphoblastic Leukemia. Acta Haematol 1988, 80 (4), 199-202.
https://doi.org/10.1159/000205637 [DOI:10.1159/000205637.]
12. Subramaniam, H. N.; Chaubal, K. A. Evaluation of Intracellular Lipids by Standardized Staining with a Sudan Black B Fraction. Journal of Biochemical and Biophysical Methods 1990, 21 (1), 9-16.
https://doi.org/10.1016/0165-022X(90)90040-J [DOI:10.1016/0165-022X(90)90040-J.]
13. Cohn, P.; Emanuel, P.; Bozdech, M. Differences in Nonspecific Esterase from Normal and Leukemic Monocytes. Blood 1987, 69 (6), 1574-1579.
https://doi.org/10.1182/blood.V69.6.1574.1574 [DOI:10.1182/blood.V69.6.1574.1574.]
14. Van Der Pan, K.; De Bruin-Versteeg, S.; Damasceno, D.; Hernández-Delgado, A.; Van Der Sluijs-Gelling, A. J.; Van Den Bossche, W. B. L.; De Laat, I. F.; Díez, P.; Naber, B. A. E.; Diks, A. M.; Berkowska, M. A.; De Mooij, B.; Groenland, R. J.; De Bie, F. J.; Khatri, I.; Kassem, S.; De Jager, A. L.; Louis, A.; Almeida, J.; Van Gaans-van Den Brink, J. A. M.; Barkoff, A.-M.; He, Q.; Ferwerda, G.; Versteegen, P.; Berbers, G. A. M.; Orfao, A.; Van Dongen, J. J. M.; Teodosio, C. Development of a Standardized and Validated Flow Cytometry Approach for Monitoring of Innate Myeloid Immune Cells in Human Blood. Front. Immunol. 2022, 13, 935879.
https://doi.org/10.3389/fimmu.2022.935879 [DOI:10.3389/fimmu.2022.935879.]
15. Guruprasad, K. P.; Vasudev, V.; Agrawal, H.; Thakur, M.; Krishan, A.; Sobti, R. C. Flow Cytometry: Historical Perspectives, Fundamentals, Past and Present Instrumentations, and Applications. In Flow Cytometry; Sobti, R. C., Krishan, A., Agrawal, D. K., Eds.; Springer Nature Singapore: Singapore, 2024; pp 1-25.
https://doi.org/10.1007/978-981-97-4553-1_1 [DOI:10.1007/978-981-97-4553-1_1.]
16. Rahman, K. Flow Cytometry Based Residual Disease Monitoring in Haematolymphoid Neoplasm. In Flow Cytometry; Sobti, R. C., Krishan, A., Agrawal, D. K., Eds.; Springer Nature Singapore: Singapore, 2024; pp 319-346.
https://doi.org/10.1007/978-981-97-4553-1_19 [DOI:10.1007/978-981-97-4553-1_19.]
17. Peters, J. M.; Ansari, M. Q. Multiparameter Flow Cytometry in the Diagnosis and Management of Acute Leukemia. Archives of Pathology & Laboratory Medicine 2011, 135 (1), 44-54.
https://doi.org/10.5858/2010-0387-RAR.1 [DOI:10.5858/2010-0387-RAR.1.]
18. Denys, B.; Van Der Sluijs-Gelling, A. J.; Homburg, C.; Van Der Schoot, C. E.; De Haas, V.; Philippé, J.; Pieters, R.; Van Dongen, J. J. M.; Van Der Velden, V. H. J. Improved Flow Cytometric Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia. Leukemia 2013, 27 (3), 635-641.
https://doi.org/10.1038/leu.2012.231 [DOI:10.1038/leu.2012.231.]
19. Diamond, L. W.; Nguyen, D. T.; Andreeff, M.; Maiese, R. L.; Braylan, R. C. A Knowlewldge‐based System for the Interpretation of Flow Cytometry Data in Leukemias and Lymphomas. Cytometry 1994, 17 (3), 266-273.
https://doi.org/10.1002/cyto.990170310 [DOI:10.1002/cyto.990170310.]
20. Varma, N.; Naseem, S. Application of Flow Cytometry in Pediatric Hematology‐oncology. Pediatric Blood & Cancer 2011, 57 (1), 18-29.
https://doi.org/10.1002/pbc.22954 [DOI:10.1002/pbc.22954.]
21. Lacombe, F.; Belloc, F. Flow Cytometry Study of Cell Cycle, Apoptosis and Drug Resistance in Acute Leukemia. Hematol Cell Ther 1996, 38 (6), 495-504.
https://doi.org/10.1007/s00282-996-0495-9 [DOI:10.1007/s00282-996-0495-9.]
22. Brown, M.; Wittwer, C. Flow Cytometry: Principles and Clinical Applications in Hematology. Clinical Chemistry 2000, 46 (8), 1221-1229.
https://doi.org/10.1093/clinchem/46.8.1221 [DOI:10.1093/clinchem/46.8.1221.]
23. Theunissen, P.; Mejstrikova, E.; Sedek, L.; Van Der Sluijs-Gelling, A. J.; Gaipa, G.; Bartels, M.; Sobral Da Costa, E.; Kotrová, M.; Novakova, M.; Sonneveld, E.; Buracchi, C.; Bonaccorso, P.; Oliveira, E.; Te Marvelde, J. G.; Szczepanski, T.; Lhermitte, L.; Hrusak, O.; Lecrevisse, Q.; Grigore, G. E.; Froňková, E.; Trka, J.; Brüggemann, M.; Orfao, A.; Van Dongen, J. J. M.; Van Der Velden, V. H. J. Standardized Flow Cytometry for Highly Sensitive MRD Measurements in B-Cell Acute Lymphoblastic Leukemia. Blood 2017, 129 (3), 347-357.
https://doi.org/10.1182/blood-2016-07-726307 [DOI:10.1182/blood-2016-07-726307.]
24. Karawajew, L.; Dworzak, M.; Ratei, R.; Rhein, P.; Gaipa, G.; Buldini, B.; Basso, G.; Hrusak, O.; Ludwig, W.-D.; Henze, G.; Seeger, K.; Von Stackelberg, A.; Mejstrikova, E.; Eckert, C. Minimal Residual Disease Analysis by Eight-Color Flow Cytometry in Relapsed Childhood Acute Lymphoblastic Leukemia. Haematologica 2015, 100 (7), 935-944.
https://doi.org/10.3324/haematol.2014.116707 [DOI:10.3324/haematol.2014.116707.]
25. Modvig, S.; Hallböök, H.; Madsen, H. O.; Siitonen, S.; Rosthøj, S.; Tierens, A.; Juvonen, V.; Osnes, L. T. N.; Vålerhaugen, H.; Hultdin, M.; Matuzeviciene, R.; Stoskus, M.; Marincevic, M.; Lilleorg, A.; Ehinger, M.; Norén-Nystrøm, U.; Toft, N.; Taskinen, M.; Jónsson, O. G.; Pruunsild, K.; Vaitkeviciene, G.; Vettenranta, K.; Lund, B.; Abrahamsson, J.; Porwit, A.; Schmiegelow, K.; Marquart, H. V. Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor ALL in a Multicenter Setting. Leukemia 2021, 35 (7), 1894-1906.
https://doi.org/10.1038/s41375-020-01100-5 [DOI:10.1038/s41375-020-01100-5.]
26. Vredenburgh, J. J.; Silva, O.; Tyer, C.; DeSOMBRE, K.; Abou-Ghalia, A.; Cook, M.; Layfield, L.; Peters, W. P.; Bast, R. C. A Comparison of Immunohistochemistry, Two-Color Immunofluorescence, and Flow Cytometry with Cell Sorting for the Detection of Micrometastatic Breast Cancer in the Bone Marrow. Journal of Hematotherapy 1996, 5 (1), 57-62.
https://doi.org/10.1089/scd.1.1996.5.57 [DOI:10.1089/scd.1.1996.5.57.]
27. Wyatt, J. I.; Quirke, P.; Ward, D. C.; Clayden, A. D.; Dixon, M. F.; Johnston, D.; Bird, C. C. Comparison of Histopathological and Flow Cytometric Parameters in Prediction of Prognosis in Gastric Cancer. The Journal of Pathology 1989, 158 (3), 195-201.
https://doi.org/10.1002/path.1711580305 [DOI:10.1002/path.1711580305.]
28. Gerstner, A. O. H.; Mittag, A.; Laffers, W.; Dähnert, I.; Lenz, D.; Bootz, F.; Bocsi, J.; Tárnok, A. Comparison of Immunophenotyping by Slide-Based Cytometry and by Flow Cytometry. Journal of Immunological Methods 2006, 311 (1-2), 130-138.
https://doi.org/10.1016/j.jim.2006.01.012 [DOI:10.1016/j.jim.2006.01.012.]
29. Tworek, J. A.; Singleton, T. P.; Schnitzer, B.; Hsi, E. D.; Ross, C. W. Flow Cytometric and Immunohistochemical Analysis of Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, and Plasmacytoid Small Lymphocytic Lymphoma. Am J Clin Pathol 1998, 110 (5), 582-589.
https://doi.org/10.1093/ajcp/110.5.582 [DOI:10.1093/ajcp/110.5.582.]
30. Ahuja, A.; Tyagi, S.; Seth, T.; Pati, H. P.; Gahlot, G.; Tripathi, P.; Somasundaram, V.; Saxena, R. Comparison of Immunohistochemistry, Cytochemistry, and Flow Cytometry in AML for Myeloperoxidase Detection. Indian J Hematol Blood Transfus 2018, 34 (2), 233-239.
https://doi.org/10.1007/s12288-017-0849-1 [DOI:10.1007/s12288-017-0849-1.]
31. Paredes‐Aguilera, R.; Romero‐Guzman, L.; Lopez‐Santiago, N.; Burbano‐Ceron, L.; Camacho‐Del Monte, O.; Nieto‐Martinez, S. Flow Cytometric Analysis of Cell‐surface and Intracellular Antigens in the Diagnosis of Acute Leukemia. American J Hematol 2001, 68 (2), 69-74.
https://doi.org/10.1002/ajh.1155 [DOI:10.1002/ajh.1155.]
32. Guillaume, N.; Penther, D.; Vaida, I.; Gruson, B.; Harrivel, V.; Claisse, J. . F.; Capiod, J. C.; Lefrere, J. J.; Damaj, G. CD66c Expression in B‐cell Acute Lymphoblastic Leukemia: Strength and Weakness. Int J Lab Hematology 2011, 33 (1), 92-96.
https://doi.org/10.1111/j.1751-553X.2010.01254.x [DOI:10.1111/j.1751-553X.2010.01254.x.]
33. Liu, M.; Weng, X.; Gong, S.; Chen, H.; Ding, J.; Guo, M.; Hu, X.; Wang, J.; Yang, J.; Tang, G. Flow Cytometric Analysis of CD64 Expression Pattern and Density in the Diagnosis of Acute Promyelocytic Leukemia: A Multi-Center Study in Shanghai, China. Oncotarget 2017, 8 (46), 80625-80637.
https://doi.org/10.18632/oncotarget.20814 [DOI:10.18632/oncotarget.20814.]
34. Lam, G.; Punnett, A.; Stephens, D.; Sung, L.; Abdelhaleem, M.; Hitzler, J. Value of Flow Cytometric Analysis of Peripheral Blood Samples in Children Diagnosed with Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer 2018, 65 (1), e26738.
https://doi.org/10.1002/pbc.26738 [DOI:10.1002/pbc.26738.]
35. Raskovalova, T.; Berger, M. G.; Jacob, M.-C.; Park, S.; Campos, L.; Aanei, C. M.; Kasprzak, J.; Pereira, B.; Labarère, J.; Cesbron, J.-Y.; Veyrat-Masson, R. Flow Cytometric Analysis of Neutrophil Myeloperoxidase Expression in Peripheral Blood for Ruling out Myelodysplastic Syndromes: A Diagnostic Accuracy Study. Haematologica 2019, 104 (12), 2382-2390.
https://doi.org/10.3324/haematol.2018.202275 [DOI:10.3324/haematol.2018.202275.]
36. Zhang, X.; Wang, L.-P.; Ziober, A.; Zhang, P. J.; Bagg, A. Ionized Calcium Binding Adaptor Molecule 1 (IBA1). American Journal of Clinical Pathology 2021, 156 (1), 86-99.
https://doi.org/10.1093/ajcp/aqaa209 [DOI:10.1093/ajcp/aqaa209.]
37. Rollins‐Raval, M. A.; Roth, C. G. The Value of Immunohistochemistry for CD14, CD123, CD33, Myeloperoxidase and CD68R in the Diagnosis of Acute and Chronic Myelomonocytic Leukaemias. Histopathology 2012, 60 (6), 933-942.
https://doi.org/10.1111/j.1365-2559.2012.04175.x [DOI:10.1111/j.1365-2559.2012.04175.x.]
38. Deghady, A. A. M.; Mansour, A. R.; Elfahham, assma A. A. A. E. The Value of Cytochemical Stains in the Diagnosis of Acute Leukemia. International Journal For Research In Health Sciences And Nursing 2016, 2 (5).
39. Resende, G. A. D.; Gileno, M. da C.; Moraes-Souza, H.; Carlos, A. M.; Leal, A. S.; Martins, P. R. J. The Role of Cytochemistry in the Diagnosis of Acute Leukemias. International Journal of Health Sciences and Research 2017, 7 (8).
40. Hamid, Dr. G. A.; Harize, Dr. I. B. BONE MARROW MORPHOLOGY AND CYTOCHEMICAL STAINING IN DIAGNOSIS AND CLASSIFICATION OF ACUTE LEUKEMIA. European Journal of Biomedical AND Pharmaceutical sciences 2018, 5 (8), 574-583.
41. Venkatesan, S.; Boj, S.; Nagaraj, S. A STUDY OF CLINICO-HEMATOLOGICAL PROFILE IN ACUTE LEUKEMIA WITH CYTOCHEMICAL CORRELATION. International Journal of Academic Medicine and Pharmacy 2023, 5 (4), 893-898. [DOI:10.47009/jamp.2023.5.4.181.]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
- Iranian Journal of Blood and Cancer
- Journal Tel: +989369936116
- Publisher Tel: +982122275917
- Mail: Info@ijbc.ir
